Products & Solutions
-
Solvias Capabilities Update March 2026: Analytical Services
3/24/2026
A biotech leader highlights end‑to‑end analytical capabilities from development to commercialization, with expertise in biologics, gene therapies, quality testing, and regulatory solutions.
-
Oligonucleotides LC-MS: Support From Development To Release
2/18/2026
A clear look at analytical strategies that strengthen oligonucleotide development, from LC‑MS identity and purity checks to potency assessment, ensuring confidence from early development through release.
-
Monoclonal Antibodies & Antibody-Drug Conjugates
2/18/2026
A clear overview of analytical solutions for mAbs and ADCs, covering structural characterization, potency, genetic QC, stability, and biosafety. Learn how comprehensive testing supports safer, more consistent biologics from early development through commercial release.